Evidence map›Paper›PMID 38226489›Full record

ArticleThe neuroradiology journal2024

Prevalence of Scarpa's ganglion enhancement on high-resolution MRI imaging.

Clayton Siminski, John C Benson, Matthew L Carlson, John I Lane

Open access · greenAbstract read
In one paragraph

Article in The neuroradiology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Clayton SiminskiDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-0670-0668
John C BensonDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-4038-5422
Matthew L CarlsonDepartment of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, MN, USA.
John I LaneDepartment of Radiology, Mayo Clinic, Rochester, MN, USA.
Mayo Clinic in Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe vestibular ganglion, or Scarpa's ganglion, is a cluster of afferent vestibular neurons within the internal auditory canal (IAC). There is minimal literature describing enhancement of this region on magnetic resonance imaging (MRI) and its correlation to clinical symptoms. Here, we sought to find the prevalence of enhancement at Scarpa's ganglion, and determine whether such enhancement correlates with demographics or clinical symptoms. MATERIALS AND

methodsA retrospective review was performed of consecutive patients with an MRI of the IAC between 3/1/2021 and 5/20/2021. Two neuroradiologists independently reviewed for T1 and FLAIR enhancement of the Scarpa's ganglion on post-contrast fat-saturated T1 and post-contrast FLAIR images. Discrepancies were agreed upon by consensus. Clinical variables (hearing loss, vestibular symptoms, tinnitus, and MRI indication) were gathered from a retrospective chart review.

resultsEighty-nine patients were included (51 female); the mean age was 58 (range 19-85). The most common MRI indication was hearing loss (

conclusionsEnhancement is present in the minority of patients on post-contrast FLAIR images. If seen, it should be considered an uncommon but not unexpected finding with no clinical significance.

Indexed as

Magnetic Resonance ImagingAdultAgedAged, 80 and overFemaleHearing LossHumansMaleMiddle AgedPrevalenceRetrospective StudiesTinnitusYoung Adultmagnetic resonance imagingScarpa’s ganglionvestibular ganglion

Identifiers

PMID38226489
PMCPMC11138325
OpenAlexW4390918004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.